These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9369533)

  • 41. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption.
    Kusano K; Miyaura C; Inada M; Tamura T; Ito A; Nagase H; Kamoi K; Suda T
    Endocrinology; 1998 Mar; 139(3):1338-45. PubMed ID: 9492070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy.
    Webster L; Chignell AH; Limb GA
    Exp Eye Res; 1999 Jan; 68(1):91-8. PubMed ID: 9986746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.
    Mirastschijski U; Impola U; Karsdal MA; Saarialho-Kere U; Agren MS
    J Invest Dermatol; 2002 Jan; 118(1):55-64. PubMed ID: 11851876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy.
    Kon CH; Occleston NL; Charteris D; Daniels J; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1524-9. PubMed ID: 9660504
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours.
    Rooprai HK; Van Meter T; Rucklidge GJ; Hudson L; Everall IP; Pilkington GJ
    Int J Oncol; 1998 Dec; 13(6):1153-7. PubMed ID: 9824624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
    Tetlow LC; Adlam DJ; Woolley DE
    Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
    Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
    Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia.
    Clark AW; Krekoski CA; Bou SS; Chapman KR; Edwards DR
    Neurosci Lett; 1997 Nov; 238(1-2):53-6. PubMed ID: 9464653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing.
    Moses MA; Marikovsky M; Harper JW; Vogt P; Eriksson E; Klagsbrun M; Langer R
    J Cell Biochem; 1996 Mar; 60(3):379-86. PubMed ID: 8867813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
    Kikkawa F; Tamakoshi K; Nawa A; Shibata K; Yamagata S; Yamagata T; Suganuma N
    Cancer Lett; 1997 Nov; 120(1):109-15. PubMed ID: 9570393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures.
    Kawashima-Ohya Y; Satakeda H; Kuruta Y; Kawamoto T; Yan W; Akagawa Y; Hayakawa T; Noshiro M; Okada Y; Nakamura S; Kato Y
    Endocrinology; 1998 Apr; 139(4):2120-7. PubMed ID: 9529001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of matrix metalloproteinase and TIMP expression in chronic ulcers.
    Saarialho-Kere UK
    Arch Dermatol Res; 1998 Jul; 290 Suppl():S47-54. PubMed ID: 9710383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of metalloproteinases in fifty joint fluid specimens.
    Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
    Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
    Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal activity of plasminogen activators and matrix metalloproteinases during cutaneous wound repair.
    Arumugam S; Jang YC; Chen-Jensen C; Gibran NS; Isik FF
    Surgery; 1999 Jun; 125(6):587-93. PubMed ID: 10372023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds.
    Vaalamo M; Weckroth M; Puolakkainen P; Kere J; Saarinen P; Lauharanta J; Saarialho-Kere UK
    Br J Dermatol; 1996 Jul; 135(1):52-9. PubMed ID: 8776359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
    Zeng ZS; Cohen AM; Guillem JG
    Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
    Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
    J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.